醒脑静注射液治疗脑梗死合并高同型半胱氨酸血症43例临床观察.docVIP

精品论文 参考文献 醒脑静注射液治疗脑梗死合并高同型半胱氨酸血症43例临床观察 刘雪花 （河源市人民医院药剂科 广东河源 517000） 【摘要】目的：观察醒脑静注射液对脑梗死合并高同型半胱氨酸血症患者的临床疗效。方法：将本院83例脑梗死合并高同型半胱氨酸血症患者随机分为对照组40例和醒脑静注射液治疗组43例，对照组予以控制血压、血脂、血糖，抗血小板聚集等常规治疗，治疗组在对照组治疗方案的基础上加用醒脑静注射液治疗，疗程为7天，分别观察两组患者治疗前后神经功能缺损程度评分及血浆同型半胱氨酸水平。结果：醒脑静注射液治疗组患者治疗后临床神经功能缺损程度及血浆同型半胱氨酸水平均较治疗前有所改善（p＜0.05），改善程度优于对照组（p＜0.05）。结论：醒脑静注射液能够有效改善脑梗死合并高同型半胱氨酸血症患者的临床神经缺损程度及血浆同型半胱氨酸水平。 【关键词】醒脑静注射液 脑梗死 高同型半胱氨酸血症 临床观察 【中图分类号】R453 【文献标识码】A 【文章编号】2095-1752（2013）22-0392-02 Xingnaojing Injection clinical observation of treatment of 43 cases with cerebral infarction and hyperhomocysteinemia. Author:LIU xuehua Dept. of Pharmacy, Heyuan Municipal Peoplersquo;s Hospital, Heyuan 517000, China 【Abstract】Objective To observe the clinical efficacy of Xingnaojing Injection in patients with cerebral infarction and hyperhomocysteinemia. Methods Randomly dividing 83 patients with cerebral infarction and hyperhomocysteinemia in our hospital into the control group of 40 cases and Xingnaojing Injection treatment group of 43 cases. Control group treated with conventional therapy, including control blood pressure, blood lipids, blood glucose, anti-platelet aggregation and so on.Xingnaojing Injection treatment group on the basis of the control group treatment programs plus with the hospital preparation Fucong balsam treatment, course of 7 days.Neurological deficit scores and plasma homocysteine levels in the two groups of patients before and after treatment were observed. Result Xingnaojing Injection treatment group improved both clinical neurological deficit and plasma homocysteine level than before treatment(plt;0.05), and the improvement greater than the control group(plt;0.05). Conclusion Xingnaojing Injection can effectively improve cerebral infarction and hyperhomocysteinemia in patients with clinical neurological deficit and plasma homocysteine levels. 【Key words】Xingnaojing Injection cerebral infarction hyperhomocysteinemia clini